Skip Ribbon Commands
Skip to main content
 
IMI consultation on advanced therapies
26/09/2016
|
 
​The EBMT has contributed to the Innovative Medicines Intiative
​The EBMT has contributed to the Innovative Medicines Intiative (IMI) consultation on advanced therapies responding to the IMI's proposals in this fast-moving field that includes cellular therapy. All submissions including the EBMT's were published on the IMI web site on 15 September and will be further discussed at the IMI Stakeholder Forum on 29 September (see link for more information on the Forum).
IMI is the world's biggest public-private partnership (PPP) in the life sciences. Through the IMI 2 programme, it has a €3.3 billion budget for the period 2014-2024. More information can be found here.
 

 News

 
15/03/2017
​March 2017 | Volume 56 - Issue 2... Read more >>
05/10/2016
​EBMT TV returns to 2017 Annual Meeting... Read more >>
26/09/2016
​The EBMT has contributed to the Innovative Medicines Intiative... Read more >>
10/05/2016
​More than 60 EBMT centres have already started entering their related donor data. We want to invite... Read more >>
 

 Events